Protocol No
HJKC3-0003
Principal Investigator
Ehab Atallah
Phase
II
Summary
The purpose of this study is to determine if adding asciminib to imatinib prior to a second attempt at stopping imatinib will lead to prolonged treatment free remission.
Description
Treatment Free Remission After Asciminib plus Imatinib in CP-CML
Participating Institutions
Karmanos Cancer Institute
Froedtert Hospital
Status
OPEN TO ACCRUAL
Sub Category
ClinicalTrials.gov